Department of Pharmacology, Second Military Medical University, 325 Guo He Road, Shanghai 200433, China.
Department of Pharmacology, Second Military Medical University, 325 Guo He Road, Shanghai 200433, China Department of Pharmacy, General Hospital of Lanzhou Military Region, Lanzhou, China.
Cardiovasc Res. 2014 Dec 1;104(3):477-88. doi: 10.1093/cvr/cvu220. Epub 2014 Oct 23.
Intracellular nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD(+)) biosynthesis. This study investigated the role of NAMPT-mediated NAD(+) signalling in post-ischaemic vascular repair.
Mouse hind-limb ischaemia up-regulated NAMPT expression and NAD(+) level in bone marrow (BM). Pharmacological inhibition of NAMPT by a chemical inhibitor FK866 impaired the mobilization of endothelial progenitor cells (EPCs) from BM upon ischaemic stress. Transgenic mice overexpressing NAMPT (Tg mice), but not H247A-mutant dominant-negative NAMPT (DN-Tg mice), exhibited enhanced capillary density, increased number of proliferating endothelial cells, improved blood flow recovery, and augmented collateral arterioles in the ischaemic limb. In cultured BM-derived EPCs, inhibition of NAMPT suppressed proliferation, migration, and tube formation, whereas overexpression of NAMPT induced opposite effects. The promoting effects of NAMPT on EPCs were abolished by silencing of sirtuin 1 (SIRT1), rather than silencing of SIRT2-7. Overexpression of NAMPT led to a SIRT1-depedent enhancement of Notch-1 intracellular domain deacetylation, which inhibited Delta-like ligand-4 (DLL4)-Notch signalling and thereby up-regulated of VEGFR-2 and VEGFR-3. Injection of recombinant VEGF induced a more pronounced EPC mobilization in Tg, but not in DN-Tg, mice. Furthermore, overexpression of NAMPT down-regulated Fringe family glycosyltransferases in a SIRT1-dependent manner, which rendered Notch more sensitive to the pro-angiogenic ligand Jagged1 rather than the anti-angiogenic ligand DLL4.
These results demonstrate that intracellular NAMPT-NAD(+)-SIRT1 cascade improves post-ischaemic neovascularization. The modulation of Notch signalling may contribute to the enhanced post-ischaemic neovascularization.
细胞内烟酰胺磷酸核糖转移酶(NAMPT)是烟酰胺腺嘌呤二核苷酸(NAD(+))生物合成的限速酶。本研究探讨了 NAMPT 介导的 NAD(+)信号在缺血后血管修复中的作用。
小鼠后肢缺血上调骨髓(BM)中 NAMPT 的表达和 NAD(+)水平。化学抑制剂 FK866 抑制 NAMPT 可损害缺血应激时 BM 内皮祖细胞(EPC)的动员。过表达 NAMPT(Tg 小鼠)而非 H247A 突变显性负性 NAMPT(DN-Tg 小鼠)的转基因小鼠,缺血肢体的毛细血管密度增加,增殖内皮细胞数量增加,血流恢复改善,侧支小动脉增加。在培养的 BM 来源的 EPC 中,抑制 NAMPT 抑制增殖、迁移和管形成,而过表达 NAMPT 则诱导相反的作用。沉默 SIRT1(而不是 SIRT2-7)可消除 NAMPT 对 EPC 的促进作用。NAMPT 的过表达导致 Notch-1 细胞内结构域去乙酰化的 SIRT1 依赖性增强,从而抑制 Delta 样配体 4(DLL4)-Notch 信号,并上调 VEGFR-2 和 VEGFR-3。重组 VEGF 的注射在 Tg 但不是在 DN-Tg 小鼠中引起更明显的 EPC 动员。此外,NAMPT 的过表达以 SIRT1 依赖的方式下调 Fringe 家族糖基转移酶,从而使 Notch 对促血管生成配体 Jagged1 而不是抗血管生成配体 DLL4 更敏感。
这些结果表明,细胞内 NAMPT-NAD(+)-SIRT1 级联反应改善了缺血后新血管形成。Notch 信号的调节可能有助于增强缺血后新血管形成。